Combined delivery of the adiponectin gene and rosiglitazone using cationic lipid emulsions

International Journal of Pharmaceutics

Volumn 483, Issue 1-2, 2015, Pages 124-130

  Davaa, Enkhzaya ^a   Kang, Bong Seok ^a   Han, Joo Hui ^a   Lee, Sang Eun ^a   Ng, Choon Lian ^a   Myung, Chang Seon ^a   Park, Jeong Sook ^a  

^a Chungnam National University   (South Korea)

Author keywords

Adiponectin; Cationic emulsion; Gene delivery; Rosiglitazone; Type 2 diabetes

Indexed keywords

ADIPONECTIN; LIPID EMULSION; PLASMID DNA; POLYSORBATE 20; POLYSORBATE 80; ROSIGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CATION; DNA; EMULSION; LIPID;

ARTICLE; CARCINOMA CELL; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TARGET CELL; ZETA POTENTIAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; EMULSION; GENETICS; HEPG2 CELL LINE; SURFACE PROPERTY; TUMOR CELL CULTURE;

ADIPONECTIN; CATIONS; CELL SURVIVAL; DNA; DRUG DELIVERY SYSTEMS; EMULSIONS; HEP G2 CELLS; HUMANS; LIPIDS; PARTICLE SIZE; SURFACE PROPERTIES; THIAZOLIDINEDIONES; TUMOR CELLS, CULTURED;

EID: 84923116676     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.02.015     Document Type: Article

References (21)

1. O. Astapova, and T. Leff Adiponectin and PPARγ: cooperative and interdependent actions of two key regulators of metabolism Vitam. Horm. 90 2012 143 162
2. W.J. Choi, J.K. Kim, S.H. Choi, J.S. Park, W.S. Ahn, and C.K. Kim Low toxicity of cationic lipid-based emulsion for gene transfer Biomaterials 25 2004 5893 5903
3. H. Chung, T.W. Kim, M. Kwon, I.C. Kwon, and S.Y. Jeong Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system J. Control. Release 71 2001 339 350
4. K.A. Coughlan, R.J. Valentine, N.B. Ruderman, and A.K. Saha AMPK activation: a therapeutic target for type 2 diabetes? Diabetes Metab. Syndr. Obes. 7 2014 241 253
5. E. Davaa, U.H. Jeong, B.K. Shin, S.G. Choi, C.S. Myung, and J.S. Park Complexation of adiponectin-encoding plasmid DNA with rosiglitazone-loaded cationic liposomes J. Pharm. Invest. 40 2010 357 362
6. E. Davaa, and J.S. Park Formulation parameters influencing the physicochemical characteristics of rosiglitazone-loaded cationic lipid emulsion Arch. Pharm. Res. 35 2012 1205 1213
7. E. Davaa, I.H. Ahn, B.S. Kang, S.E. Lee, C.S. Myung, and J.S. Park Preliminary study to determine the optimal conditions for the simultaneous complexation of siRNA and plasmid DNA J. Pharm. Invest. 43 2013 499 505
8. L.G. Fryer, A. Parbu-Pate, and D. Carling The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways J. Biol. Chem. 277 2002 25226 25232
9. U.H. Jeong, J.H. Jung, E. Davaa, S.J. Park, C.S. Myung, and J.S. Park Effect of drug loading on the physicochemical properties and stability of cationic lipid based plasmid DNA complexes J. Kor. Pharm. 39 2009 339 343
10. U.H. Jeong, V.K. Garripelli, S. Jo, C.S. Myung, S.J. Hwang, J.K. Kim, and J.S. Park Potential of pH-sensitive polymer-anchored cationic liposomes for combinatorial anticancer therapy with doxorubicin and siRNA J. Drug Del. Sci. Technol. 24 2014 27 32
11. H.S. Kang, S.J. Jin, C.S. Myung, S.J. Hwang, and J.S. Park Delivery of interleukin-18 gene to lung cancer cells using cationic emulsion J. Drug Target. 17 2009 19 28
12. S.Y. Kim, S.J. Lee, and S.J. Lim Formulation and in vitro and in vivo evaluation of a cationic emulsion as a vehicle for improving adenoviral gene transfer Int. J. Pharm. 475 2014 49 59
13. N. Kubota, Y. Terauchi, T. Kubota, H. Kumagai, S. Itoh, H. Satoh, W. Yano, H. Ogata, K. Tokuyama, I. Takamoto, T. Mineyama, M. Ishikawa, M. Moroi, K. Sugi, T. Yamauchi, K. Ueki, K. Tobe, T. Noda, R. Nagai, and T. Kadowaki Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways J. Biol. Chem. 281 2006 8748 8755
14. N.K. LeBrasseur, M. Kelly, T.S. Taso, S.R. Farmer, A.K. Saha, N.B. Ruderman, and E. Tomas Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues Am. J. Physiol. Endocrinol. Metab. 291 2006 E175 E181
15. B.H. Liu, Y.C. Wang, S.C. Wu, H.J. Mersmann, W.T.K. Cheng, and S.T. Ding Insulin regulates the expression of adiponectin and adiponectin receptors in porcine adipocytes Domest. Anim. Endocrin. 34 2008 352 359
16. Y. Lustig, R. Hemi, and H. Kanety Regulation and function of adiponectin receptors in skeletal muscle Vitam. Horm. 90 2012 95 123
17. M.H. Nan, J.S. Park, and C.S. Myung Construction of adiponectin-encoding plasmid DNA and gene therapy of non-obese type 2 diabetes mellitus J. Drug Target 18 2010 67 77
18. A.R. Nawrocki, M.W. Rajala, E. Tomas, U.B. Pajvani, A.K. Saha, M.E. Trumbauer, Z. Pang, A.S. Chen, N.B. Ruderman, H. Chen, L. Rossetti, and P.E. Scherer Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists J. Biol. Chem. 281 2006 2654 2660
19. H. Suzuki, and S. Eguchi Adiponectin versus angiotensin II: key pathological role of their misbalance Kidney Int. 70 2006 1678 1679
20. N. Wiradharma, Y.W. Tong, and Y.Y. Yang Self-assembled oligpnucleotide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect Biomaterials 30 2009 3100 3109
21. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, O. Ezaki, Y. Akanuma, O. Gavrilova, C. Vinson, M.L. Reitman, H. Kagechika, K. Shudo, M. Yoda, Y. Nakano, K. Tobe, R. Nagai, S. Kimura, M. Tomita, P. Froguel, and T. Kadowaki The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat. Med. 7 2001 941 946